The 17th edition of CPHI & PMEC India, organized by Informa Markets in India, opened today at the India Expo Centre, highlighting the remarkable growth and global impact of India’s pharmaceutical industry. With the Indian pharma market projected to grow to USD 130 billion by 2030 and USD 450 billion by 2047, the event underlines the industry’s pivotal role in shaping global healthcare.
Attracting over 2,000 exhibitors and 50,000 visitors from 150+ countries, including the USA, UAE, South Korea, Japan, and the UK, the expo is a vibrant hub of innovation and collaboration. It spans diverse segments of the pharmaceutical ecosystem, including manufacturing, packaging, analytical instruments, laboratory technologies, and ingredients, fostering transformative dialogues and strategic partnerships.
Grand Inauguration by Industry Leaders
The event was inaugurated by an esteemed panel of dignitaries, including Mr. K. Raja Bhanu, Director General, Pharmexcil; Mr. Harish K. Jain, President, FOPE; Mr. Namit Joshi, Vice Chairman, Pharmexcil; Ms. Rhonda Duffy, COO, Biocon Biologics; and Mr. Yogesh Mudras, Managing Director, Informa Markets in India, among others. Their presence set the tone for a spectacular showcase of the future of pharmaceuticals and healthcare.
Innovations and Exhibitors Take Center Stage
Leading pharmaceutical giants such as Dr. Reddy’s Laboratories, Biocon Ltd, Glenmark Lifesciences, Lupin Ltd, and Merck Life Science are among the exhibitors, alongside PMEC participants like ACG, Parle Global Technologies, and Cadmach Machinery, showcasing cutting-edge advancements in pharma manufacturing equipment and innovation.
Mr. AVPS Chakravarthy, Global Ambassador, World Packaging Organisation, emphasized, “India’s pharmaceutical industry is at the forefront of innovation, with breakthroughs like Carticel therapy and AI-driven drug inspections. CPHI & PMEC India serves as a vital platform to propel this progress further.”
Sector Insights and Future Projections
The expo also hosted key discussions on the pharmaceutical industry’s growth trajectory. Mr. Harish K. Jain, President of FOPE, highlighted India’s $60 billion pharmaceutical industry’s contribution to global exports and its potential to reach $1 trillion by 2047. Similarly, Mr. K. Raja Bhanu, Director General of Pharmexcil, noted that exports, currently at $27.85 billion, are expected to grow to $130 billion by 2030.
Day 1 Highlights and Key Discussions
The Pharma Connect Congress addressed critical themes, including agile manufacturing for next-gen therapeutics, digital transformation, and India’s role as the “Pharmacy of the World.” Day 1 concluded with the prestigious India Pharma Awards 2024, celebrating excellence in innovation, sustainability, and R&D.
Looking Ahead: Day 2 Themes
As per the press release, day 2 will focus on sustainability and leadership in pharma, with sessions on ESG practices, green chemistry, and the evolving role of women in the industry. The Women in Pharma Roundtable aims to inspire greater participation and leadership by women in the sector.
Empowering the Future of Pharma
CPHI India and PMEC India provide a comprehensive platform for stakeholders across the pharmaceutical manufacturing and biopharma industries, driving growth, innovation, and collaboration. By showcasing India’s strengths in cost-efficient manufacturing, R&D, and skilled labor, the event reinforces the nation’s position as a global leader in pharmaceuticals and healthcare.